Oslo University Hospital has awarded 6 excellent articles for the first half-year of 2024
In order to stimulate excellent research and draw attention to the hospital's research activity, Oslo University Hospital rewards outstanding publications every half-year.
Six research groups were awarded for their excellent papers published the first half-year of 2024 during a ceremony on November 28th. Each group received NOK 50.000 earmarked for further research, and the prize winners gave short presentations of their main findings.
The award winners have contributed new knowledge about the prevention of dementia, functional organization of brain fluid transport, neoadjuvant treatment of pancreatic cancer, the influence of a gluten-free diet on the immune system, molecular classification and heterogeneity in colon cancer and the development of a broad-spectrum influenza vaccine. The winning articles provide a good picture of the thematic breadth of research at OUS and that results are delivered within disease treatment and prevention with great societal benefit, says Research Director Erlend Smeland, who distritubed the awards.
The awards for outstanding research articles are awarded twice a year based on over 2,400 scientific articles published annually by OUS. The clinics' research committees nominate the articles and an external committee evaluates and finally selects the six worthy winners.
The winning articles must have achieved international impact or have distinguished themselves in other ways. The articles must also be of exceptionally high quality and communicate important findings.
News article, including popular science summaries of the findings and the committee's statements:
(in Norwegian)
Priser til fremragende forskningsartikler publisert våren 2024 (www.oslo-universitetssykehus.no)
Award-winning articles, first half-year of 2024
Can a cognitively demanding professional life protect against dementia and cognitive decline?
- Trine Holt Edwin et al.
Edwin TH, Håberg AK, Zotcheva E, Bratsberg B, Jugessur A, Engdahl B, Bowen C, Selbæk G, Kohler HP, Harris JR, Tom SE, Krokstad S, Mekonnen T, Stern Y, Skirbekk VF, Strand BH (2024)
Trajectories of Occupational Cognitive Demands and Risk of Mild Cognitive Impairment and Dementia in Later Life: The HUNT4 70+ Study
Neurology, 102 (9), e209353
DOI 10.1212/WNL.0000000000209353, PubMed 38630959
New insights into the organization of the cerebrospinal fluid transport system may impact treatment of brain diseases
- Per Kristian Eide and Geir Ringstad
Eide PK, Ringstad G (2024)
Functional analysis of the human perivascular subarachnoid space
Nat Commun, 15 (1), 2001
DOI 10.1038/s41467-024-46329-1, PubMed 38443374
FOLFIRINOX chemotherapy before surgery does not show improved survival for patients with pancreatic cancer
- Knut Jørgen Labori et al.
Labori KJ, Bratlie SO, Andersson B, Angelsen JH, Biörserud C, Björnsson B, Bringeland EA, Elander N, Garresori H, Grønbech JE, Haux J, Hemmingsson O, Liljefors MG, Myklebust TÅ, Nymo LS, Peltola K, Pfeiffer P, Sallinen V, Sandström P, Sparrelid E, Stenvold H, Søreide K, Tingstedt B, Verbeke C, Öhlund D et al. (2024)
Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial
Lancet Gastroenterol Hepatol, 9 (3), 205-217
DOI 10.1016/S2468-1253(23)00405-3, PubMed 38237621
Gluten-free diet triggers rapid changes in immune cells in celiac disease patients
- Louise Fremgaard Risnes et al.
Risnes LF, Reims HM, Doyle RM, Qiao SW, Sollid LM, Lundin KEA, Christophersen A (2024)
Gluten-Free Diet Induces Rapid Changes in Phenotype and Survival Properties of Gluten-Specific T Cells in Celiac Disease
Gastroenterology, 167 (2), 250-263
DOI 10.1053/j.gastro.2024.03.027, PubMed 38552723
Classification of bowel cancer in the context of molecular tumor heterogeneity
- Jonas Langerud et al.
Langerud J, Eilertsen IA, Moosavi SH, Klokkerud SMK, Reims HM, Backe IF, Hektoen M, Sjo OH, Jeanmougin M, Tejpar S, Nesbakken A, Lothe RA, Sveen A (2024)
Multiregional transcriptomics identifies congruent consensus subtypes with prognostic value beyond tumor heterogeneity of colorectal cancer
Nat Commun, 15 (1), 4342
DOI 10.1038/s41467-024-48706-2, PubMed 38773143
Development of a new broad-spectrum influenza vaccine
- Daniëla Maria Hinke et al.
Hinke DM, Anderson AM, Katta K, Laursen MF, Tesfaye DY, Werninghaus IC, Angeletti D, Grødeland G, Bogen B, Braathen R (2024)
Applying valency-based immuno-selection to generate broadly cross-reactive antibodies against influenza hemagglutinins
Nat Commun, 15 (1), 850
DOI 10.1038/s41467-024-44889-w, PubMed 38346952